3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.
3D Medicines, we use individual’s genetic information to prevent, diagnose, and treat cancer. We develop personalized medicines according to target population’s genetic background, to increase efficacy and safety.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 15, 2022 | IPO | $251.10M | — | — | — | Detail |
Nov 1, 2020 | Series D | — | 1 | — | — | Detail |
Oct 19, 2020 | Private Equity(PE) | ¥1.50B | 11 | CPE | — | Detail |
Oct 9, 2020 | Series Unknown | $140M | 7 | China Capital Management EFung Capital | — | Detail |
Jan 6, 2020 | Series Unknown | ¥280M | 6 | China Resources Pharmaceutical Industry Investment Fund | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 16, 2015
Motion AI
|
Seed | $700K | Artificial Intelligence | — |
Apr 1, 2011
Moon Active
|
Pre-seed | — | Gaming | — |